Events for you

This event features 3 to 5 pre-screened startups pitching to an audience of active investors in New York City. It is designed for angel investors, VC partners, scouts, and analysts focused on evaluating and advancing deal flow. Attendees gain direct access to founders and ongoing deal opportunities aligned with their investment thesis.

This event features 3 to 5 pre-screened startups pitching to a focused audience of active investors in Boston. It is designed for angel investors, VC partners, scouts, and analysts who want to evaluate deals and access high-signal investment opportunities. Attendees gain direct founder access, live presentations with Q&A, and ongoing deal pipeline benefits.

This event features 3 to 5 pre-screened startups presenting to approved investors in Houston. It provides direct access to founders with live pitches and Q&A, focusing on active deal evaluation rather than general networking. Investors benefit from weekly deal flow and ongoing founder introductions after attending.

This event brings together biotech founders, investors, researchers, and industry professionals for networking and pitching opportunities in South Miami. Founders have the chance to deliver brief pitches to investors seeking innovative biotech startups. Attendees can form strategic partnerships, gain industry insights, and expand their professional network within the biotech and life sciences sectors.

This event features 3 to 5 vetted startups pitching live to accredited investors in Austin. It is designed for angel investors, VC partners, scouts, and analysts who want direct access to founders and clear investment signals. Attendees come to evaluate deals efficiently and receive ongoing deal flow and founder introductions after the event.

This event provides biotech founders the opportunity to pitch their innovations to investors and industry professionals in New York City. Attendees can network with a diverse group of experts across biotech, medtech, and pharma sectors to explore funding, partnerships, and industry trends. The event supports collaboration and growth within the biotechnology and life sciences ecosystem.

This event brings together biotech founders, investors, and professionals for networking and pitching opportunities in Los Angeles. Attendees can give quick pitches to investors and connect with experts across biotech, medtech, and pharmaceutical industries. The event aims to facilitate funding, partnerships, and knowledge exchange in biotechnology and life sciences.

This event brings together biotech startup founders, investors, researchers, and professionals for pitching and networking opportunities in San Francisco. Attendees can deliver brief pitches, connect with potential investors, and build relationships with experts across biotech, medtech, and pharma sectors. The goal is to foster collaboration and support growth within the biotech and life sciences ecosystem.

This event features 3 to 5 pre-screened startups presenting live pitches in Zurich to investors looking to evaluate deals. Attendees are mostly angel investors, VC partners, and deal scouts focusing on sectors like AI, Web3, and HealthTech. The night aims to create a focused environment for deal flow and founder access rather than general networking.

This event features 3 to 5 pre-screened startups pitching live to an audience of investors in Amsterdam. It is designed for angel investors, VCs, scouts, and analysts who seek direct access to founders and investment opportunities in sectors like AI, Web3, and HealthTech. Attendees evaluate deals in a focused environment and gain ongoing deal flow and founder connections after the event.

This event features 3 to 5 pre-screened startups pitching live to a focused audience of active investors in Los Angeles. Attendees are primarily angel investors, VC partners, scouts, and analysts evaluating deal flow and engaging directly with founders. The event is designed to facilitate serious investment assessment and ongoing deal pipeline access beyond the session.

This event features a focused investor session where 3 to 5 pre-screened startups present investment opportunities in a direct, deal-driven environment. It is designed for active angel investors, VC partners, scouts, analysts, and founders in sectors like AI, Web3, and HealthTech. Participants evaluate deals, engage with founders, and access ongoing deal flow and founder introductions after the event.

This Investor Day at Switzerland Innovation Park Basel Area focuses on biotech and life sciences startups pitching to investors active in the sector. It is designed for founders seeking investment and investors looking to discover promising startups within one of Europe’s leading life sciences hubs. The event facilitates connections and investment opportunities in the broad life sciences spectrum.